Global Proteomics Market

Proteomics Market Size, Share, Growth Analysis, By Product(Services, Reagents & Consumables), By Technology(Microarray Instruments, X-Ray Crystallography), By Application(Drug Discovery, Clinical Diagnostics) - Industry Forecast 2024-2031

Report ID: SQMIG35G2281 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 94 | Figures: 76

Proteomics Market Insights

Proteomics Market size was valued at USD 25.2 billion in 2019 and is poised to grow from USD 29.35 billion in 2023 to USD 100.17 billion by 2031, growing at a CAGR of 16.55% in the forecast period (2024-2031).

According to Globocan, there will be 19.3 million new cases of cancer worldwide in December 2020, with 10 million cancer-related deaths reported. CVDs are also one of the leading causes of death worldwide. According to the WHO (2021), target diseases kill 41 million people each year. Thus, as the prevalence of life-threatening diseases rises, so does the demand for personalised therapies, resulting in a positive impact on the industry. Another factor expected to drive proteomics market growth is the rising prevalence of chronic diseases such as cancer, cardiovascular Diseases (CVDs), respiratory diseases, CKD, and others.

Increased investments in proteomics R&D are a growth driver in the field of proteomics. The National Institutes of Health (NIH) of the United States provided $37 billion for biomedical research. This funding was intended to support life sciences research that sought to understand the fundamental processes by which diseases develop, such as the identification of biomarkers that indicate the presence of disease or the identification of the gene/protein responsible for the disease. The Novo Nordisk Foundation awarded the University of Copenhagen a grant of up to $1.5 million to establish a mass spectrometry facility, which is a significant step forward in protein research. The Global Proteomics Market is also expected to pick up steam following the consistent resumption of the activities in the midst of the pandemic which has caused a worldwide disruption in operating activities.

US Proteomics Market is poised to grow at a sustainable CAGR for the next forecast year.

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Proteomics Market size was valued at USD 25.2 billion in 2019 and is poised to grow from USD 29.35 billion in 2023 to USD 100.17 billion by 2031, growing at a CAGR of 16.55% in the forecast period (2024-2031).

To increase their industry presence, key players are implementing various strategies such as mergers and acquisitions, geographical expansion, and strategic collaborations. Seer, Inc., for example, announced the Broad Commercial Release of The Proteograph Product Suite and the Centers of Excellence programme in January 2022. The Proteograph Product Suite provides unbiased, unrivalled access to the proteome. The method employs specially designed nanoparticles to create a game-changing product that enables rapid, thorough, and unbiased proteomics at scale. 'Bio-Rad Laboratories, Inc. ', 'GE Healthcare ', 'Creative Proteomics ', 'Thermo Fisher Scientific Inc.', 'Agilent Technologies Inc.', 'Danaher Corporation', 'Merck KGaA', 'Bruker Corporation', 'Waters Corporation', 'PerkinElmer Inc.', 'Shimadzu Corporation', 'Biognosys AG', 'Luminex Corporation', 'Promega Corporation', 'Proteome Sciences plc', 'Genedata AG', 'GenScript Biotech Corporation', 'Bioproximity LLC', 'Applied Proteomics Inc.', 'Avant Diagnostics Inc.'

Several significant discoveries were made in the field of life sciences, one of which was the completion of the human genome sequencing. The characterization of human protein was the next significant biomedicine milestone, which is a relatively new and extremely dynamic branch of science focused on evaluating gene expression at the proteome level. With limited research in proteomics to date, current proteomics can only address a few issues, such as protein identification, quantification, characterization of post-translational modifications, structure and function elucidation, and description of potential interactions.

Nanotechnology has been linked to several proteomics applications, including phosphor proteomics/metal oxide nanoparticles, nanostructured surfaces for protein separation, and array-based analytical detection of biomarker proteins. As a result, Nano proteomics, a science involving the application of proteomics techniques aided by nanotechnology, has emerged. This technique is used in conjunction with other nanotechnology applications to revolutionize proteomics, such as nano porous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures.

The global proteomics market is studied on the basis of geography as North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America dominated the industry in 2021, accounting for 45% of total revenue. This is due to increased investments in structure-based drug design, growth in omics research, demand for high-quality research tools for data reproducibility, and focus on the development of tailored treatments. Partnerships and collaborations among major companies in this region are also assisting in the market's expansion. Thermo Fisher Scientific Inc. and Symphogen, for example, collaborated to develop validated platform processes for the streamlined characterization and quality monitoring of complex therapeutic proteins.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.


Feedback From Our Clients

Global Proteomics Market

Product ID: SQMIG35G2281